Alpha lipoic Acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials
This 2012 meta-analysis evaluated the efficacy of alpha-lipoic acid (ALA) in treating symptomatic peripheral neuropathy in diabetic patients. The analysis included randomized controlled trials using the Total Symptom Score (TSS) to assess outcomes. Results showed a significant reduction in TSS favoring ALA treatment, with both oral and intravenous forms proving
June 26, 2025
No Comments